SK Biopharmaceuticals Co Ltd

326030

Company Profile

  • Business description

    SK Biopharmaceuticals Co Ltd is a pharmaceutical company engaged in research and development of new drugs for treatment of central nervous system (CNS) disorders. The company is also researching for the development of drugs to treat brain tumors, including metastatic tumors. It has a Bio Science Research Institute in Pangyo Techno Valley in Gyeonggi Province. Its drugs in pipeline include Cenobamate, Solriamfetol, Carisbamate, Relenopride, SKL13865, SKL20540, SKL-PSY, and SKL24741.

  • Contact

    221, Pangyoyeok-ro
    Bundang-gu
    Gyeonggi-do
    Seongnam-si13494
    KOR

    T: +82 3180930114

    https://www.skbp.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    265

Stocks News & Analysis

stocks

Insignia Financial: Revised deal still attractive

The offer price is well above our fair value.
stocks

Undervalued ASX income play

Major development projects remain on schedule.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

With the monetization of GenAI, here’s what we think of Alphabet’s stock

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,007.0065.500.73%
CAC 407,744.4153.81-0.69%
DAX 4024,041.90265.90-1.09%
Dow JONES (US)44,502.44179.370.40%
FTSE 1009,023.8110.820.12%
HKSE25,460.54330.511.32%
NASDAQ20,892.6981.49-0.39%
Nikkei 22541,307.011,532.093.85%
NZX 50 Index12,794.0639.68-0.31%
S&P 5006,309.624.020.06%
S&P/ASX 2008,743.6066.400.77%
SSE Composite Index3,596.6814.820.41%

Market Movers